Bank of New York Mellon Corp Sells 13,159 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Bank of New York Mellon Corp reduced its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 9.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 132,286 shares of the company's stock after selling 13,159 shares during the period. Bank of New York Mellon Corp owned 0.88% of U.S. Physical Therapy worth $11,735,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp boosted its holdings in U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company's stock valued at $56,522,000 after acquiring an additional 99,244 shares during the period. Copeland Capital Management LLC lifted its position in shares of U.S. Physical Therapy by 9.5% during the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company's stock worth $74,459,000 after purchasing an additional 72,715 shares during the last quarter. Southernsun Asset Management LLC boosted its stake in U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company's stock valued at $46,302,000 after purchasing an additional 52,062 shares during the period. Rockefeller Capital Management L.P. grew its holdings in U.S. Physical Therapy by 18.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company's stock valued at $13,578,000 after buying an additional 25,393 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its position in U.S. Physical Therapy by 283.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company's stock worth $1,425,000 after buying an additional 12,445 shares during the period.

Remove Ads

Insider Buying and Selling

In related news, COO Graham D. Reeve sold 1,730 shares of U.S. Physical Therapy stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.70% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

USPH has been the subject of several research reports. Barrington Research reduced their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday, February 28th. William Blair reissued a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an "outperform" rating and a $113.00 price objective on the stock. Citizens Jmp upgraded shares of U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. Finally, StockNews.com lowered U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $111.50.

U.S. Physical Therapy Price Performance

NYSE:USPH traded down $0.07 during mid-day trading on Monday, hitting $76.42. The company's stock had a trading volume of 97,553 shares, compared to its average volume of 98,496. The company has a market capitalization of $1.16 billion, a price-to-earnings ratio of 81.30, a P/E/G ratio of 3.54 and a beta of 1.51. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a fifty-two week low of $76.05 and a fifty-two week high of $113.63. The stock has a fifty day moving average of $86.17 and a 200-day moving average of $87.37.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. As a group, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a $0.45 dividend. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 annualized dividend and a dividend yield of 2.36%. U.S. Physical Therapy's dividend payout ratio is presently 97.83%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.